Clinical and serological prognostic markers in primary biliary cholangitis
Clinical and Molecular Hepatology. 2021;27(2):360-361 
Comment on “Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis”
Disease Markers. 2020;2020:1-2
Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
JGH Open. 2019;4(2):132-139
Serological markers of rheumatoid arthritis in patients with primary biliary cholangitis and the vice versa: A Tunisian study
Immunobiology. 2023;228(4):152398
Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markers
Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(3):52-63
Primary Biliary Cholangitis
Clinical Cases in Hepatology. 2021;27-84
Autoimmune Markers in Primary Biliary Cholangitis
Clinics in Liver Disease. 2023;
Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis
The Korean Journal of Pancreas and Biliary Tract. 2020;25(2):107-117
Biochemical and Serological Markers of Liver Function in Liver Transplant Recipients with Primary Biliary Cholangitis
Journal of Hepatology. 2016;64(2):S542
Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Other Cholestatic Liver Diseases
Current Clinical Medicine. 2010;552-557.e1